US Patent 7282506 2,8-disubstituted naphthyridine derivatives
Patent 7282506 was granted and assigned to Serenex on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+52 characters)
Article
Patent abstract
Disclosed are compounds of formula A:
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07282506 2,8-disubstituted naphthyridine derivatives US Patent 7282506 2,8-disubstituted naphthyridine derivatives
Infobox
Patent Number
0728250600
Patent Number
728250600
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072825060
Date of Patent
October 16, 2007
0Patent Application Number
111965320
Date Filed
August 3, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072825060
Date of Patent
October 16, 2007
0Patent Application Number
111965320
Date Filed
August 3, 2005
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07282506 2,8-disubstituted naphthyridine derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07282506
Date of patent
October 16, 2007
Patent application number
11196532
Date Filed
August 3, 2005
Patent primary examiner
Find more entities like US Patent 7282506 2,8-disubstituted naphthyridine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.